Dear Client,
As part of our ongoing commitment to ensuring the security of your online trading experience, we would like to inform you of our protocol for addressing any suspicious activities observed on your trading account
Should you notice any irregularities or suspect unauthorized access to your account, we kindly request that you take immediate action by following the steps outlined below:
Send an Email Please send an email to stoptrade@acml.in from your registered email ID. In the email, briefly outline the suspicious activity you have observed.
Phone Call Alternatively, you can call us at 07965081981 Ext: 4 from your registered mobile number. This will enable us to address your concerns promptly.
When contacting us, please ensure you provide the following details:
By providing this information, you enable us to swiftly investigate and take appropriate measures to safeguard your account.
Your security and peace of mind are of utmost importance to us, and we appreciate your cooperation in maintaining the integrity of your trading account.
Zydus Lifesciences Ltd announced on September 11, 2026, that CRISIL Ratings Limited reviewed and reaffirmed the credit ratings of its various instruments and facilities, as detailed in letters dated September 10, 2026, including a long term rating of CRISIL AAA/Stable and a short term rating of CRISIL A1+ for Various Bank Facilities amounting to Rs. 4,724 crore; a short term rating of CRISIL A1+ for Commercial Papers (CPs) with an authorized limit of Rs. 200 crore; a rating of CRISIL AAA/Stable for Non-Convertible Debentures (NCDs) with an outstanding limit of Rs. 50 crore; and a rating of CRISIL AAA/Stable for another instrument with an outstanding limit of Rs. 75 crore, noting that there are currently no outstanding Commercial Papers or Non-Convertible Debentures.